Cognizance Biomarkers Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Cognizance Biomarkers General Information


Operator of a neurology and neuroinflammation-focused diagnostics company intended to achieve leadership in proteomic and genomic-based testing for improved diagnosis and treatment of neurological disorders, offering rapid, accurate and cost-effective precision medicine solutions for optimal patient outcomes. The company's diagnostic test identifies molecules that are indicative of these inflammation-induced seizures, enabling doctors to diagnose and treat people with non-epileptic seizures.

Contact Information

Ownership Status
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Corporate Office
  • 3160 Chestnut Street
  • Suite 200
  • Philadelphia, PA 19104
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cognizance Biomarkers Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Jan-2015 Completed Startup
3. Grant 01-Jan-2015 00000 Completed Startup
2. Accelerator/Incubator 09-Apr-2013 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Cognizance Biomarkers’s complete valuation and funding history, request access »

Cognizance Biomarkers Patents

Cognizance Biomarkers Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024001063-A Biomarkers and methods for evaluation and treatment of epileptic seizures versus nonepileptic seizures/no seizures/psychogenic nonepileptic seizures Pending 29-May-2018 000000000
JP-2023153888-A Biomarkers and methods for detection of seizures and epilepsy Pending 16-May-2017 00000000000

Cognizance Biomarkers Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Penn Center for Innovation Accelerator/Incubator Minority 000 0000 000000 0
Science Center Accelerator/Incubator Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Cognizance Biomarkers’s complete investors history, request access »

Cognizance Biomarkers FAQs

  • When was Cognizance Biomarkers founded?

    Cognizance Biomarkers was founded in 2012.

  • Where is Cognizance Biomarkers headquartered?

    Cognizance Biomarkers is headquartered in Philadelphia, PA.

  • What industry is Cognizance Biomarkers in?

    Cognizance Biomarkers’s primary industry is Biotechnology.

  • Is Cognizance Biomarkers a private or public company?

    Cognizance Biomarkers is a Private company.

  • What is Cognizance Biomarkers’s current revenue?

    The current revenue for Cognizance Biomarkers is 000000.

  • Who are Cognizance Biomarkers’s investors?

    Penn Center for Innovation, Science Center, and U.S. Department of Health and Human Services have invested in Cognizance Biomarkers.

  • When was Cognizance Biomarkers acquired?

    Cognizance Biomarkers was acquired on 01-Jan-2015.

  • Who acquired Cognizance Biomarkers?

    Cognizance Biomarkers was acquired by Evogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »